Malaysian high-net-worth families are showing growing appetite for Alpine properties, attracted by both capital preservation ...
Swiss drugmaker Novartis on Monday defended its $12 billion deal to acquire Avidity Biosciences ahead of the U.S. firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback